Company Filing History:
Years Active: 1995-2000
Title: The Innovations of Hideto Kaneshima
Introduction
Hideto Kaneshima is a prominent inventor based in Palo Alto, CA (US). He has made significant contributions to the field of biomedical research, particularly in the area of hematopoiesis and antiviral therapies. With a total of 9 patents to his name, Kaneshima's work has the potential to impact medical science profoundly.
Latest Patents
One of Kaneshima's latest patents is titled "Extended human hematopoiesis in a heterologous host." This invention provides a human hematopoietic system in an immunocompromised mammalian host, allowing for extended functionality over time. The method involves introducing human fetal liver tissue and human fetal thymus into a young immunocompromised mouse, resulting in the novel formation of functional human bone marrow tissue. Another significant patent is the "Method for screening potential therapeutically effective antiviral agents." This invention outlines methods for screening agents for their potential antiviral effects by assessing their ability to suppress viral replication and pathology in thymic cells grown in organ culture.
Career Highlights
Hideto Kaneshima is currently associated with Systemix, Inc., where he continues to innovate and develop new technologies. His work has garnered attention in the scientific community, and he is recognized for his contributions to advancing medical research.
Collaborations
Throughout his career, Kaneshima has collaborated with notable colleagues, including Joseph M McCune and Reiko Namikawa. These collaborations have further enriched his research and expanded the impact of his inventions.
Conclusion
Hideto Kaneshima's innovative work in hematopoiesis and antiviral therapies showcases his dedication to advancing medical science. His patents reflect a commitment to finding solutions that could lead to significant breakthroughs in healthcare.